8 Things to Know about COVID-19 Vaccine Planning
Planning is underway at the federal and state levels.
While there is currently no authorized or approved vaccine to prevent COVID-19, the U.S. government’s Operation Warp Speed program has been working since the pandemic started to make a COVID-19 vaccine available as soon as possible.
There may be a limited supply of COVID-19 vaccines before the end of 2020. If there is limited supply, some groups may be recommended to get a COVID-19 vaccine first. Find out the 8 things you need to know about vaccine planning.
1. The safety of COVID-19 vaccines is a top priority.
The U.S. vaccine safety system ensures that all vaccines are as safe as possible. Learn how federal partners are working together to ensure the safety of COVID-19 vaccines.
2. Many vaccines are being developed and tested, but some might be ready before others—CDC is planning for many possibilities.
CDC is working with partners at all levels of government to plan for different vaccines and scenarios. CDC is in contact with your state public health department to begin planning. State, tribal, local, and territorial health departments are critical to making sure vaccines are available to communities.
3. At least at first, COVID-19 vaccines might be used under an Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA).
Learn more about FDA’s Emergency Use Authorization authorityexternal icon and watch a video on what an EUA is.
4. There may be a limited supply of COVID-19 vaccines before the end of 2020, but supply will continually increase in the weeks and months that follow.
The goal is for everyone to be able to easily get a COVID-19 vaccine as soon as large quantities are available. The plan is to have several thousand vaccination providers available so no one will have to travel far to be vaccinated, whether it’s at your doctor’s office, retail pharmacy, hospital, or federally qualified health center.
Learn about how the federal government began investing in select vaccine manufacturersexternal icon to help them increase their ability to quickly make and distribute a large amount of COVID-19 vaccine.
5. If there is limited supply, some groups may be recommended to get a COVID-19 vaccine first.
Experts are working on how to distribute these limited vaccines in a fair, ethical, and transparent way. The National Academies of Sciences, Engineering, and Medicine (NASEM) gave inputexternal icon to the Advisory Committee on Immunization Practices, which will make recommendations to the CDC director once a vaccine(s) is authorized or approved for use.
6. At first, COVID-19 vaccines may not be recommended for children.
In early clinical trialsexternal icon for various COVID-19 vaccines, only non-pregnant adults participated. However, clinical trials continue to expand those recruited to participate. The groups recommended to receive the vaccines could change in the future.
7. Cost will not be an obstacle to getting vaccinated against COVID-19.
The federal government is committed to providing free or low-cost COVID-19 vaccines. Vaccine doses purchased with U.S. taxpayer dollars will be given to the American people at no cost. However, vaccine providers will be able to charge administration fees for giving or administering the shot to someone. Most public and private insurance companies will cover that fee so there is no cost for the person getting vaccinated. In addition, people without health insurance can get COVID-19 vaccines at no cost.
8. COVID-19 vaccine planning is being updated as new information becomes available.
CDC will continue to update this website as plans develop.
Washington’s ‘Interim COVID-19 Vaccination Plan’ submitted to CDC
The Washington State Department of Health submitted its interim vaccination plan for COVID-19 vaccine distribution to the Centers for Disease Control and Prevention (CDC) by the stated deadline of October 16, 2020. Click here for more information on the proposed plan.
COVID-19 information pages are no longer updated.
See the CDC's COVID website for current information and trends.